Cargando…

Phase I oncology trials incorporating patient choice of dose

BACKGROUND: Patients recruited in phase I oncology trials are often treated at doses lower than the maximum tolerated dose (MTD), and therefore may not receive the most efficacious dose available, despite their expectations to the contrary. This report investigates the consequences of allowing a pat...

Descripción completa

Detalles Bibliográficos
Autor principal:	Huson, L W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461169/ https://www.ncbi.nlm.nih.gov/pubmed/22929891 http://dx.doi.org/10.1038/bjc.2012.378

Ejemplares similares

Informed Consent for Phase I Oncology Trials: Form, Substance and Signature
por: Malik, Laeeq, et al.
Publicado: (2014)

Trends in the crossover of patients in phase III oncology clinical trials in the USA
por: Yeh, Justin, et al.
Publicado: (2020)

A Phase I trial of talazoparib in patients with advanced hematologic malignancies
por: Gopal, Ajay K, et al.
Publicado: (2021)

Bridging across patient subgroups in phase I oncology trials that incorporate animal data
por: Zheng, Haiyan, et al.
Publicado: (2021)

A phase I/II multicentric trial of gemcitabine and epirubicin in patients with advanced pancreatic carcinoma
por: Eickhoff, A, et al.
Publicado: (2006)

On the choice of methodology for evaluating dose-rate effects on radiation-related cancer risks
por: Walsh, Linda, et al.
Publicado: (2021)

Strength and weakness of phase I to IV trials, with an emphasis on translational aspects
por: Lønning, Per Eystein
Publicado: (2008)

A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours
por: Lassen, U, et al.
Publicado: (2012)

Phase I dose-escalation oncology trials with sequential multiple schedules
por: Günhan, Burak Kürsad, et al.
Publicado: (2021)

Novel sulphonamides incorporating triazene moieties show powerful carbonic anhydrase I and II inhibitory properties
por: Bilginer, Sinan, et al.
Publicado: (2019)

Bayesian dose regimen assessment in early phase oncology incorporating pharmacokinetics and pharmacodynamics
por: Gerard, Emma, et al.
Publicado: (2021)

Randomized adjuvant trials in oncology: a necessity or time-consuming luxury?
por: Ragaz, Joseph
Publicado: (2010)

Pharmacokinetics of Vancomycin in Oncology Egyptian Paediatrics: A Dosage Adjustment Trial
por: Mahmoud, M. A., et al.
Publicado: (2014)

A phase II trial of gefitinib with 5-fluorouracil, leucovorin, and irinotecan in patients with colorectal cancer
por: Veronese, M L, et al.
Publicado: (2005)

Challenges of Incorporating Digital Health Technology Outcomes in a Clinical Trial: Experiences from PD STAT
por: Day, Jacob O., et al.
Publicado: (2022)

Incorporating the patient perspective in the study of rare bone disease: insights from the osteogenesis imperfecta community
por: Swezey, T., et al.
Publicado: (2018)

Multidisciplinary neurosurgical rounds incorporating antimicrobial stewardship. Are they of benefit?
por: Creedon, M., et al.
Publicado: (2022)

Integration of palliative care in oncology—the intersection of cultures and perspectives of oncology and palliative care
por: Lundeby, Tonje, et al.
Publicado: (2022)

Current and future choices in endocrine therapy
por: Ellis, Matthew
Publicado: (2007)

A phase 1 Bayesian dose selection study of bortezomib and sunitinib in patients with refractory solid tumor malignancies
por: Harvey, R D, et al.
Publicado: (2013)

Ultrasound findings in Kaposi sarcoma patients: overlapping sonographic features with disseminated tuberculosis
por: Huson, Michaela Aurelia Maria, et al.
Publicado: (2023)

Practical considerations for the implementation of adaptive designs for oncology Phase I dose-finding trials
por: Wei, Lai, et al.
Publicado: (2019)

A phase-I, open label clinical trial to assess the safety & tolerability of qHPV vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults
por: Sharma, Hitt, et al.
Publicado: (2023)

Phase I study of cisplatin analogue nedaplatin (254-S) and paclitaxel in patients with unresectable squamous cell carcinoma
por: Sekine, I, et al.
Publicado: (2004)

The state of medical oncology in Senegal
por: Diop, Mamadou
Publicado: (2019)

Developing medical oncology in Africa
por: Busakhala, Naftali
Publicado: (2019)

Pragmatic dose-escalation methods incorporating relative dose intensity assessment for molecularly targeted agents in phase I trials
por: Hirakawa, Akihiro, et al.
Publicado: (2019)

Results of a phase I, open-label, randomized, crossover study evaluating the effects of linifanib on QTc intervals in patients with solid tumors
por: Chiu, Yi-Lin, et al.
Publicado: (2013)

Familial diagnostic experiences in paediatric oncology
por: Evans, N T, et al.
Publicado: (2015)

A current view of oncology in Argentina
por: Huñis, Adrián Pablo
Publicado: (2016)

Dostarlimab: A breakthrough in the field of oncology
por: Hussain, Hassan ul, et al.
Publicado: (2022)

Temporal metabolic response to mRNA COVID-19 vaccinations in oncology patients
por: Advani, Pooja, et al.
Publicado: (2021)

Intermediate- to high-dose dexamethasone versus low-dose dexamethasone in patients with COVID-19 requiring respiratory support: a systematic review and meta-analysis of randomized trials
por: Kow, Chia Siang, et al.
Publicado: (2023)

Phase I clinical trial of nintedanib plus paclitaxel in early HER-2-negative breast cancer (CNIO-BR-01-2010/GEICAM-2010-10 study)
por: Quintela-Fandino, M, et al.
Publicado: (2014)

A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma
por: Bydder, S, et al.
Publicado: (2004)

The gender authorship gap in gynecologic oncology research()
por: Penn, Courtney A., et al.
Publicado: (2019)

Availability of Essential Medicines for Pediatric Oncology in Armenia
por: Simonyan, Tamara, et al.
Publicado: (2019)

The effects of anesthetic drug choice on heart rate variability in dogs
por: Pattanapon, Nakrob, et al.
Publicado: (2018)

Multimodal analysis and the oncology patient: Creating a hospital system for integrated diagnostics and discovery
por: Messiou, Christina, et al.
Publicado: (2023)

Lysozyme microspheres incorporated with anisotropic gold nanorods for ultrasound activated drug delivery
por: Bhargawa, Bharat, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qa0s2jbv6bplbtm1hfg8i6coet